Michael W. Melkus

2.0k total citations · 1 hit paper
31 papers, 1.5k citations indexed

About

Michael W. Melkus is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Michael W. Melkus has authored 31 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Michael W. Melkus's work include Immunotherapy and Immune Responses (5 papers), Virus-based gene therapy research (4 papers) and Cancer Cells and Metastasis (4 papers). Michael W. Melkus is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Virus-based gene therapy research (4 papers) and Cancer Cells and Metastasis (4 papers). Michael W. Melkus collaborates with scholars based in United States, France and China. Michael W. Melkus's co-authors include Paul W. Denton, Anja K. Wege, Jacob D. Estes, J. Víctor García, Florence A. Othieno, Ashley T. Haase, Joel Gatlin, J. Victor Garcia, Dennis A. Bente and Rebeca Rico-Hesse and has published in prestigious journals such as Nature Medicine, The Journal of Experimental Medicine and Blood.

In The Last Decade

Michael W. Melkus

27 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1

2006 509 citations Michael W. Melkus, Jacob D. Estes et al. Nature Medicine profile →

Peers

Countries citing papers authored by Michael W. Melkus

Since Specialization

Citations

This map shows the geographic impact of Michael W. Melkus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael W. Melkus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael W. Melkus more than expected).

Fields of papers citing papers by Michael W. Melkus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael W. Melkus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael W. Melkus. The network helps show where Michael W. Melkus may publish in the future.

Co-authorship network of co-authors of Michael W. Melkus

This figure shows the co-authorship network connecting the top 25 collaborators of Michael W. Melkus. A scholar is included among the top collaborators of Michael W. Melkus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael W. Melkus. Michael W. Melkus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Relevance of Cellular Homeostasis-Related Gene Expression Signatures in Distinct Molecular Subtypes of Breast Cancer 2025 ·Biomedicines ·Sharda P. Singh, Chathurika S. Dhanasekara, Michael W. Melkus, Chhanda Bose, (unknown), (unknown), (unknown), (unknown), (unknown), Se‐Ran Jun, Sahra Uygun, Rakhshanda Layeequr Rahman	0
2	Cryoablation of primary breast cancer tumors induces a systemic abscopal effect altering TIME (Tumor Immune Microenvironment) in distant tumors 2024 ·Frontiers in Immunology ·(unknown), Dalia Martinez‐Marin, (unknown), (unknown), (unknown), (unknown), Kathryn L. Furr, Isabel Castro‐Piedras, Nicholas Wagner, (unknown), (unknown), Sharda P. Singh, Kevin Pruitt, Michael W. Melkus, Rakhshanda Layeequr Rahman	2
3	Cryoablation Allows the Ultimate De-escalation of Surgical Therapy for Select Breast Cancer Patients 2023 ·Annals of Surgical Oncology ·(unknown), (unknown), (unknown), Michael W. Melkus, Rakhshanda Layeequr Rahman	7
4	Leveraging cryoablation and checkpoint inhibitors for high-risk triple negative breast cancer 2023 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), Sharda P. Singh, Rakhshanda Layeequr Rahman, Michael W. Melkus	1
5	Dishevelled 2 regulates cancer cell proliferation and T cell mediated immunity in HER2-positive breast cancer 2023 ·BMC Cancer ·Fahmida Rasha, (unknown), (unknown), Dalia Martinez‐Marin, Isabel Castro‐Piedras, Kathryn L. Furr, (unknown), (unknown), (unknown), (unknown), Hafiz Khan, Nusrat Jahan, Sharilyn Almodóvar, Michael W. Melkus, Kevin Pruitt, Rakhshanda Layeequr Rahman	8
6	ASO Author Reflections: Achieving Surgical De-Escalation of Breast Cancer Through Cryoablation 2023 ·Annals of Surgical Oncology ·Michael W. Melkus, (unknown), (unknown), Rakhshanda Layeequr Rahman	0
7	ASO Visual Abstract: Cryoablation Allows the Ultimate De-escalation of Surgical Therapy in Select Breast Cancer Patients 2023 ·Annals of Surgical Oncology ·(unknown), (unknown), (unknown), Michael W. Melkus, Rakhshanda Layeequr Rahman	1
8	Tumor-Infiltrating Lymphocytes (TILs) as a Biomarker of Abscopal Effect of Cryoablation in Breast Cancer: A Pilot Study 2022 ·Annals of Surgical Oncology ·(unknown), Michael W. Melkus, Fahmida Rasha, (unknown), (unknown), (unknown), Hafiz Khan, Harvinder Singh Gill, Kevin Pruitt, Rakhshanda Layeequr Rahman	25
9	Human Milk Endocannabinoid Levels as a Function of Obesity and Diurnal Rhythm 2021 ·Nutrients ·Palika Datta, Michael W. Melkus, Kathleen Rewers‐Felkins, Dhaval Patel, (unknown), Teresa Baker, Thomas W. Hale	9
10	Elucidation of Cellular Responses in Non-human Primates With Chronic Schistosomiasis Followed by Praziquantel Treatment 2020 ·Frontiers in Cellular and Infection Microbiology ·Michael W. Melkus, Loc Le, Arif Jamal Siddiqui, Adebayo J. Molehin, Weidong Zhang, (unknown), (unknown), (unknown)	11
11	Role of P53-Senescence Induction in Suppression of LNCaP Prostate Cancer Growth by Cardiotonic Compound Bufalin 2018 ·Molecular Cancer Therapeutics ·Yong Zhang, Yinhui Dong, Michael W. Melkus, Shutao Yin, (unknown), Peixin Jiang, Kartick C. Pramanik, Wei Wu, (unknown), Min Ye, Hongbo Hu, Junxuan Lü, Cheng Jiang	41
12	Sm-p80-based schistosomiasis vaccine mediated epistatic interactions identified potential immune signatures for vaccine efficacy in mice and baboons 2017 ·PLoS ONE ·(unknown), Michael W. Melkus, Kameswara Rao Kottapalli, (unknown), (unknown), Weidong Zhang, Adebayo J. Molehin, Darrick Carter, Afzal A. Siddiqui	14
13	Donor Dependent Variations in Hematopoietic Differentiation among Embryonic and Induced Pluripotent Stem Cell Lines 2016 ·PLoS ONE ·Olivier Féraud, Yannick Valogne, Michael W. Melkus, Yanyan Zhang, Noufϊssa Oudrhiri, Rima Haddad, (unknown), Corinne Rocher, (unknown), Philippe Duquesnoy, (unknown), Emilie Gobbo, Philippe Brunet de la Grange, Fawzia Louache, Annelise Bennaceur‐Griscelli, Maria Teresa Mitjavila‐Garcia	21
14	Biological effects of T315I-mutated BCR-ABL in an embryonic stem cell–derived hematopoiesis model 2012 ·Experimental Hematology ·Michael W. Melkus, Annelise Bennaceur‐Griscelli, Yannick Valogne, Stéphane Flamant, Jean‐Claude Chomel, Nathalie Sorel, Marie‐Laure Bonnet, Michael W. Deininger, Maria Teresa Mitjavila‐Garcia, Ali G. Turhan	6
15	Functional and Phenotypic Characterization of the Humanized BLT Mouse Model 2008 ·Current topics in microbiology and immunology ·Anja K. Wege, Michael W. Melkus, Paul W. Denton, Jacob D. Estes, J. Víctor García	116
16	Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1 2007 ·The Journal of Experimental Medicine ·Zhifeng Sun, Paul W. Denton, Jacob D. Estes, Florence A. Othieno, Bangdong L. Wei, Anja K. Wege, Michael W. Melkus, (unknown), Mary Zupancic, Ashley T. Haase, J. Víctor García	222
17	Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1 breakdown → 2006 ·Nature Medicine ·Michael W. Melkus, Jacob D. Estes, (unknown), Joel Gatlin, Paul W. Denton, Florence A. Othieno, Anja K. Wege, Ashley T. Haase, J. Victor Garcia	509
18	Dengue Fever in Humanized NOD/SCID Mice 2005 ·Journal of Virology ·Dennis A. Bente, Michael W. Melkus, J. Víctor García, Rebeca Rico-Hesse	136
19	In vivo fluorescent labeling of corneal wound healing fibroblasts 2003 ·Experimental Eye Research ·Joel Gatlin, Michael W. Melkus, (unknown), W. Matthew Petroll, H. Dwight Cavanagh, J. Víctor García, James V. Jester	18
20	The exuT Gene of Erwinia chrysanthemi EC16: Nucleotide Sequence, Expression, Localization, and Relevance of the Gene Product 1998 ·Molecular Plant-Microbe Interactions ·(unknown), Thomas L. Freeman, (unknown), Michael W. Melkus, F. Cumhur Öner, Martin Valachovič, Michael J. D. San Francisco	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact